Original source text
WASHINGTON--(BUSINESS WIRE)--Easterly Government Properties, Inc. (NYSE: DEA), a fully integrated real estate investment trust focused primarily on the acquisition, development and management of Class A commercial properties leased to the U.S. Government and its adjacent partners, announced today that its Board of Directors has approved a quarterly cash dividend of $0.45 per common share. The dividend will be payable on August 20, 2026 to shareholders of record on August 10, 2026. About Easterl. Live financial news intelligence
Track market-moving stories before they get noisy
Real-time pulse of financial headlines curated from 5 premium feeds.
Commodities
GOLD
225
SILVER
127
OIL
60
PLATINUM
5
PALLADIUM
2
COPPER
1
- FMP Stock News 25s ago
- FMP Forex News 3m ago
- CoinGecko News 3m ago
- FIO Stock News 7m ago
- Patria Stock News 7m ago
- Editorial rewrite 25s ago
- Asset sync 37m ago
Latest coverage
Market News Feed
Scan headlines quickly, then expand any story for source context.
| Details | Date | Content | Source |
|---|---|---|---|
|
Saved
2026-07-29 21:10
2d ago
Published
2026-07-29 16:30
2d ago
|
Easterly Government Properties Announces Quarterly Dividend | FMP Stock News | |
|
|
|||
|
Saved
2026-07-27 13:55
4d ago
Published
2026-07-27 07:30
4d ago
|
Glass House Brands Retains Former DEA Compliance Executive to Advise on Interstate Commerce and Export Opportunities | FMP Stock News | |
|
Original source text
LONG BEACH, Calif. and TORONTO, July 27, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (NYSE: GLAS) today announced that the Company has retained Matt Murphy, as an advisor on DEA compliance as it relates to instituting regulations related to interstate commerce and the export of medical cannabis compliant with Schedule III regulatory requirements contained in the Controlled Substances Act (CSA). |
|||
|
Saved
2026-07-07 20:59
24d ago
Published
2026-07-07 16:30
24d ago
|
Easterly Government Properties Schedules Second Quarter 2026 Earnings Release and Conference Call | FMP Stock News | |
|
Original source text
WASHINGTON--(BUSINESS WIRE)--Easterly Government Properties, Inc. (NYSE: DEA) announced today that the Company will release its second quarter 2026 financial results on August 3, 2026. A conference call will be held Monday, August 3, 2026 at 11:00am Eastern time. The management team will review second quarter performance, discuss recent events and conduct a question-and-answer session. Attendees that would like to join the call and ask a question may register here to receive the dial-in numbers. |
|||
|
Saved
2026-07-05 16:16
26d ago
Published
2026-07-05 10:15
26d ago
|
I Am Buying Real Estate Hand Over Fist, For Income And Asset Preservation | FMP Stock News | |
|
Original source text
The equity REIT sector has transformed from an obscure $9 billion alternative asset niche into a mainstream component. While top-tier momentum favorites command premium multiples, extensive pockets of the broader property market sit at deep, cyclical discounts. Multi-year compounding consumer price inflation has created a widening gap between outdated contract rates and modern market baseline values. |
|||
|
Saved
2026-07-01 23:39
30d ago
Published
2026-07-01 17:17
30d ago
|
DEA moves to place some strong kratom-related products under strict federal drug controls | FMP Stock News | |
|
Original source text
Members of the Drug Enforcement Administration (DEA) stand outside the Brooklyn Federal Courthouse in Brooklyn, New York, U.S., March 26, 2025. REUTERS/Kylie Cooper Purchase Licensing Rights, opens new tabCompaniesJuly 1 (Reuters) - The U.S. Drug Enforcement Administration on Wednesday moved to temporarily classify some strong kratom-related products under the strictest category of federal drug control, warning they act like opioids and could endanger consumers. The action targets products with elevated levels of 7-hydroxymitragynine, or 7-OH, which occurs naturally in very small amounts in kratom, a plant from Southeast Asia. But regulators say companies are selling pills, gummies, powders and liquid shots with much higher amounts. Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here. Here are further details: The Department of Health and Human Services and the Food and Drug Administration supported the move, saying it is aimed at concentrated and synthetic products rather than natural kratom leaf without enhanced levels of 7-OH. The FDA has earlier recommended scheduling the 7-OH compound as a controlled substance due to its opioid properties. The DEA proposal, due to be published in the Federal Register on July 6, would place 7-OH above a set limit into Schedule I, the strictest category under U.S. drug law. The limit would generally cover kratom plant material with more than 0.050% 7-OH by dry weight, or certain products with more than 1 milligram of 7-OH. DEA is also moving to temporarily control three lab-made 7-OH-related substances called mitragynine pseudoindoxyl, dihydro-7-hydroxymitragynine and MGM-16. Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore Our Standards: The Thomson Reuters Trust Principles., opens new tab |
|||
|
Saved
2026-06-30 14:08
1mo ago
Published
2026-06-30 08:00
1mo ago
|
Easterly Government Properties Closes Five-Year $200 Million Term Loan Facility | FMP Stock News | |
|
Original source text
WASHINGTON--(BUSINESS WIRE)--Easterly Government Properties, Inc. (NYSE: DEA) (the “Company” or “Easterly”), a fully integrated real estate investment trust focused primarily on the acquisition, development and management of Class A commercial properties leased to the U.S. Government and its adjacent partners, announced today the closing of a new five-year $200 million senior unsecured term loan facility (the “Term Loan”). The Term Loan includes an accordion feature that allows the Company to i. |
|||
|
Saved
2026-06-12 21:14
1mo ago
Published
2026-03-18 07:00
4mo ago
|
Easterly Government Properties: Long-Term Bull Case Appears To Be Strengthening | FMP Stock News | |
|
Original source text
Easterly Government Properties is regaining momentum, with sustainable growth supported by recent accretive acquisitions and a robust development pipeline. DEA reported solid 2025 results: core FFO grew 10.3% year-over-year, and revenue increased 11.2%, despite macro headwinds and a prior dividend cut. Management guides for 3% core FFO growth in 2026, underpinned by a $1.5 billion acquisition pipeline and redevelopment projects coming online through 2027. |
|||
|
Saved
2026-06-12 21:14
1mo ago
Published
2026-04-08 16:30
3mo ago
|
Easterly Government Properties Schedules First Quarter 2026 Earnings Release and Conference Call | FMP Stock News | |
|
Original source text
-WASHINGTON--(BUSINESS WIRE)--Easterly Government Properties, Inc. (NYSE: DEA) announced today that the Company will release its first quarter 2026 financial results on April 27, 2026. A conference call will be held Monday, April 27, 2026 at 11:00am Eastern time. The management team will review first quarter performance, discuss recent events and conduct a question-and-answer session. Attendees that would like to join the call and ask a question may register here to receive the dial-in numbers and unique PIN to access the call. There will also be a live audio, listen-only webcast of the call on the Investor Relations section of Easterly’s Investor Relations website at ir.easterlyreit.com. Shortly after the call, a replay of the call will be available on the Company’s website for up to twelve months. About Easterly Government Properties, Inc. Easterly Government Properties, Inc. (NYSE: DEA) is based in Washington, D.C., and focuses primarily on the acquisition, development and management of Class A commercial properties that are leased to the U.S. Government and its adjacent partners. Easterly’s experienced management team brings specialized insight into the strategy and needs of mission-critical U.S. Government agencies for properties leased to such agencies either directly or through the U.S. General Services Administration (GSA). For further information on the company and its properties, please visit www.easterlyreit.com. More News From Easterly Government Properties, Inc. Back to Newsroom |
|||
|
Saved
2026-06-12 21:14
1mo ago
Published
2026-04-22 16:30
3mo ago
|
Easterly Government Properties Announces Quarterly Dividend | FMP Stock News | |
|
Original source text
-WASHINGTON--(BUSINESS WIRE)--Easterly Government Properties, Inc. (NYSE: DEA), a fully integrated real estate investment trust focused primarily on the acquisition, development and management of Class A commercial properties leased to the U.S. Government and its adjacent partners, announced today that its Board of Directors has approved a quarterly cash dividend of $0.45 per common share. The dividend will be payable on May 21, 2026 to shareholders of record on May 7, 2026. About Easterly Government Properties, Inc. Easterly Government Properties, Inc. (NYSE: DEA) is based in Washington, D.C., and focuses primarily on the acquisition, development and management of Class A commercial properties that are leased to the U.S. Government and its adjacent partners. Easterly’s experienced management team brings specialized insight into the strategy and needs of mission-critical U.S. Government agencies for properties leased to such agencies either directly or through the U.S. General Services Administration (GSA). For further information on the company and its properties, please visit www.easterlyreit.com. More News From Easterly Government Properties, Inc. Back to Newsroom |
|||
|
Saved
2026-06-12 21:14
1mo ago
Published
2026-04-27 01:28
3mo ago
|
HG (OTCMKTS:STLY) & Easterly Government Properties (NYSE:DEA) Head-To-Head Analysis | FMP Stock News | |
|
Original source text
Posted by Defense World Staff on Apr 27th, 2026HG (OTCMKTS:STLY – Get Free Report) and Easterly Government Properties (NYSE:DEA – Get Free Report) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, earnings, risk and analyst recommendations. Profitability This table compares HG and Easterly Government Properties’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets HG 10.38% 3.91% 2.97% Easterly Government Properties 3.87% 0.94% 0.39% Valuation and Earnings This table compares HG and Easterly Government Properties”s top-line revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HG $14.74 million 1.46 $1.53 million $0.35 12.14 Easterly Government Properties $336.10 million 3.25 $13.00 million $0.28 84.15 Easterly Government Properties has higher revenue and earnings than HG. HG is trading at a lower price-to-earnings ratio than Easterly Government Properties, indicating that it is currently the more affordable of the two stocks. Risk and Volatility HG has a beta of 0.37, meaning that its share price is 63% less volatile than the S&P 500. Comparatively, Easterly Government Properties has a beta of 0.98, meaning that its share price is 2% less volatile than the S&P 500. Analyst Ratings This is a summary of recent recommendations and price targets for HG and Easterly Government Properties, as provided by MarketBeat.com. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HG 0 0 0 0 0.00 Easterly Government Properties 1 3 1 0 2.00 Easterly Government Properties has a consensus target price of $23.49, suggesting a potential downside of 0.30%. Given Easterly Government Properties’ stronger consensus rating and higher possible upside, analysts clearly believe Easterly Government Properties is more favorable than HG. Institutional & Insider Ownership 1.7% of HG shares are owned by institutional investors. Comparatively, 86.5% of Easterly Government Properties shares are owned by institutional investors. 75.0% of HG shares are owned by insiders. Comparatively, 6.5% of Easterly Government Properties shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Summary Easterly Government Properties beats HG on 9 of the 14 factors compared between the two stocks. About HG (Get Free Report) HG Holdings, Inc. engages in the title insurance and real estate businesses in the United States. It operates through four segments: Title Insurance Services, Reinsurance, Management Services, and Real Estate. The company provides title insurance, closing and/or escrow, and similar or related services in connection with residential and commercial real estate transactions. It also owns and operates a portfolio of single-tenant properties leased for the occupancy by U.S. government tenant agencies and sub-agencies, such as the Federal Bureau of Investigation, the Department of Veterans affairs, the Drug Enforcement Administration, Immigration & Customs Enforcement, the Social Security Administration, and the Department of Transportation. In addition, the company provides excess-of-loss reinsurance coverage related to catastrophic weather risk in Texas; and management advisory services, such as formation, operational, and restructuring services. The company was formerly known as Stanley Furniture Company, Inc. and changed its name to HG Holdings, Inc. in March 2018. HG Holdings, Inc. was incorporated in 1984 and is headquartered in Charlotte, North Carolina. About Easterly Government Properties (Get Free Report) Easterly Government Properties, Inc. (NYSE: DEA) is based in Washington, D.C., and focuses primarily on the acquisition, development and management of Class A commercial properties that are leased to the U.S. Government. Easterly’s experienced management team brings specialized insight into the strategy and needs of mission-critical U.S. Government agencies for properties leased to such agencies either directly or through the U.S. General Services Administration (GSA). Receive News & Ratings for HG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HG and related companies with MarketBeat.com's FREE daily email newsletter. « PREVIOUS HEADLINEHead-To-Head Analysis: CV (OTCMKTS:CVHL) & Ellington Financial (NYSE:EFC) NEXT HEADLINE »Akbank Turk Anonim Sirketi (OTCMKTS:AKBTY) and China Merchants Bank (OTCMKTS:CIHKY) Critical Review |
|||
|
Saved
2026-06-12 21:14
1mo ago
Published
2026-04-27 02:06
3mo ago
|
Easterly Government Properties (NYSE:DEA) versus Orion Office REIT (NYSE:ONL) Head to Head Comparison | FMP Stock News | |
|
Original source text
Posted by Defense World Staff on Apr 27th, 2026Orion Office REIT (NYSE:ONL – Get Free Report) and Easterly Government Properties (NYSE:DEA – Get Free Report) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, valuation, dividends, profitability and analyst recommendations. Institutional and Insider Ownership 80.0% of Orion Office REIT shares are owned by institutional investors. Comparatively, 86.5% of Easterly Government Properties shares are owned by institutional investors. 1.6% of Orion Office REIT shares are owned by company insiders. Comparatively, 6.5% of Easterly Government Properties shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Valuation and Earnings This table compares Orion Office REIT and Easterly Government Properties”s gross revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Orion Office REIT $147.65 million 0.96 -$139.31 million ($2.49) -1.01 Easterly Government Properties $336.10 million 3.25 $13.00 million $0.28 84.15 Easterly Government Properties has higher revenue and earnings than Orion Office REIT. Orion Office REIT is trading at a lower price-to-earnings ratio than Easterly Government Properties, indicating that it is currently the more affordable of the two stocks. Profitability This table compares Orion Office REIT and Easterly Government Properties’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Orion Office REIT -94.35% -20.13% -11.12% Easterly Government Properties 3.87% 0.94% 0.39% Analyst Ratings This is a breakdown of recent recommendations and price targets for Orion Office REIT and Easterly Government Properties, as provided by MarketBeat. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Orion Office REIT 1 1 1 0 2.00 Easterly Government Properties 1 3 1 0 2.00 Orion Office REIT presently has a consensus target price of $3.00, indicating a potential upside of 19.76%. Easterly Government Properties has a consensus target price of $23.49, indicating a potential downside of 0.30%. Given Orion Office REIT’s higher possible upside, analysts plainly believe Orion Office REIT is more favorable than Easterly Government Properties. Dividends Orion Office REIT pays an annual dividend of $0.08 per share and has a dividend yield of 3.2%. Easterly Government Properties pays an annual dividend of $1.80 per share and has a dividend yield of 7.6%. Orion Office REIT pays out -3.2% of its earnings in the form of a dividend. Easterly Government Properties pays out 642.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Risk and Volatility Orion Office REIT has a beta of 1.38, indicating that its stock price is 38% more volatile than the S&P 500. Comparatively, Easterly Government Properties has a beta of 0.98, indicating that its stock price is 2% less volatile than the S&P 500. Summary Easterly Government Properties beats Orion Office REIT on 11 of the 14 factors compared between the two stocks. About Orion Office REIT (Get Free Report) Orion Office REIT specializes in the ownership, acquisition and management of a diversified portfolio of mission-critical and corporate headquarters office buildings in high-quality suburban markets across the U.S. The portfolio is leased primarily on a single-tenant net lease basis to creditworthy tenants. The company's team of experienced industry leaders employs a proven, cycle-tested investment evaluation framework which serves as the lens through which capital allocation decisions are made for the current portfolio and future acquisitions. About Easterly Government Properties (Get Free Report) Easterly Government Properties, Inc. (NYSE: DEA) is based in Washington, D.C., and focuses primarily on the acquisition, development and management of Class A commercial properties that are leased to the U.S. Government. Easterly’s experienced management team brings specialized insight into the strategy and needs of mission-critical U.S. Government agencies for properties leased to such agencies either directly or through the U.S. General Services Administration (GSA). Receive News & Ratings for Orion Office REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion Office REIT and related companies with MarketBeat.com's FREE daily email newsletter. « PREVIOUS HEADLINEComparing Post (NYSE:POST) and Greenlane (NASDAQ:GNLN) NEXT HEADLINE »Analyzing Rennova Health (OTCMKTS:RNVA) & HeartSciences (NASDAQ:HSCS) |
|||
|
Saved
2026-06-12 21:14
1mo ago
Published
2026-04-27 06:30
3mo ago
|
Easterly Government Properties Reports First Quarter 2026 Results | FMP Stock News | |
|
Original source text
WASHINGTON--(BUSINESS WIRE)--Easterly Government Properties, Inc. (NYSE: DEA) (the “Company” or “Easterly”), a fully integrated real estate investment trust (“REIT”) focused primarily on the acquisition, development and management of Class A commercial properties leased to the U.S. Government and its adjacent partners, today announced its results of operations for the quarter ended March 31, 2026.Highlights for the Quarter Ended March 31, 2026: Net income of $1.4 million, or $0.03 per share on a fully diluted basis Core FFO of $37.1 million, or $0.77 per share on a fully diluted basis Acquired a 297,713 square foot campus leased primarily to the Commonwealth of Virginia with lease expirations ranging from 2027 to 2036. Entered into a mezzanine construction loan agreement to lend $7.0 million to a developer that will accrue interest monthly at a fixed market rate of 12.00% per annum. Issued an aggregate of 94,170 shares of the Company's common stock in settlement of previously entered into forward sales transactions through the Company's $300.0 million ATM Program launched in June 2021 (the “2021 ATM Program”). These shares were then physically settled in the same quarter at a weighted average price per share of $23.01, raising net proceeds to the Company of approximately $2.1 million. “We entered 2026 with clear priorities, and the first quarter demonstrates progress toward them,” said Darrell Crate, President & CEO of Easterly Government Properties. “Stable operating performance and the successful execution of our first mezzanine investment highlight our strategic approach to capital allocation and earnings growth.” Portfolio Operations As of March 31, 2026, the Company or its joint venture owned 106 operating properties in the United States encompassing approximately 10.7 million leased square feet, including 93 operating properties that were leased primarily to U.S. Government tenant agencies, eight operating properties leased primarily to tenant agencies of a U.S. state or local government and five operating properties that were entirely leased to private tenants. In addition, the Company wholly owned three properties in development that the Company expects will encompass approximately 0.2 million rentable square feet upon completion. The first development project, located in Flagstaff, Arizona, is currently under construction and, once complete, a 20-year lease with the GSA is expected to commence for the beneficial use of the United States Judiciary. The second project, located in Fort Myers, Florida, is currently under construction and, once complete, a 25-year lease with the Florida Department of Law Enforcement is expected to commence for their beneficial use. The third project, located in Medford, Oregon, is currently under construction and, once complete, a 20-year lease with the GSA is expected to commence for the beneficial use of the United States Judiciary. As of March 31, 2026, the portfolio had a weighted average age of 16.9 years, based upon the date properties were built or renovated-to-suit, and had a weighted average remaining lease term of 9.4 years. Acquisitions Activity Acquisitions On January 16, 2026, the Company acquired a 297,713 square foot campus consisting of three assets near Richmond, Virginia. The assets are leased primarily to the Commonwealth of Virginia and have lease expirations ranging from 2027 to 2036. Balance Sheet and Capital Markets Activity As of March 31, 2026, the Company had total indebtedness of approximately $1.7 billion comprised of $245.1 million outstanding on its senior unsecured revolving credit facility, $100.0 million outstanding on its 2016 term loan facility, $200.0 million outstanding on its 2018 term loan facility, $1.0 billion of senior unsecured notes, and $150.5 million of mortgage debt (excluding unamortized premiums and discounts and deferred financing fees). The Company's outstanding debt had a weighted average maturity of 3.9 years and a weighted average interest rate of 4.6%. Further, the Company's Net Debt to total enterprise value was 62.5% and its Adjusted Net Debt to annualized quarterly pro forma EBITDA ratio was 7.3x. Dividend On April 22, 2026, the Board of Directors of Easterly approved a cash dividend for the first quarter of 2026 in the amount of $0.45 per common share. The dividend will be payable May 21, 2026 to shareholders of record on May 7, 2026. Guidance This guidance is forward-looking and reflects management’s view of current and future market conditions. The Company’s actual results may differ materially from this guidance. Outlook for the 12 Months Ending December 31, 2026 The Company is raising the lower end of its guidance for full-year 2026 Core FFO per share on a fully diluted basis at a range of $3.06 - $3.12. Low High Net income (loss) per share – fully diluted basis $ 0.36 0.42 Plus: Company’s share of real estate depreciation and amortization $ 2.68 2.68 FFO per share – fully diluted basis $ 3.04 3.10 Plus: Company’s share of depreciation of non-real estate assets $ 0.02 0.02 Core FFO per share – fully diluted basis $ 3.06 3.12 This guidance assumes approximately $50 million of wholly owned acquisitions and $50 - $100 million of gross development-related investment during 2026. Non-GAAP Supplemental Financial Measures This section contains definitions of certain non-GAAP financial measures and other terms that the Company uses in this press release and, where applicable, the reasons why management believes these non-GAAP financial measures provide useful information to investors about the Company’s financial condition and results of operations and the other purposes for which management uses the measures. These measures should not be considered in isolation or as a substitute for measures of performance in accordance with GAAP. A reconciliation of the differences between each non-GAAP financial measure and the comparable GAAP financial measure are included in this press release following the consolidated financial statements. Additional detail can be found in the Company’s most recent annual report on Form 10-K and quarterly report on Form 10-Q, as well as other documents filed with or furnished to the Securities and Exchange Commission from time to time. We present certain financial information and metrics “at Easterly’s Share,” which is calculated on an entity-by-entity basis. “At Easterly’s Share” information, which we also refer to as being “at share,” “pro rata,” or “our share” is not, and is not intended to be, a presentation in accordance with GAAP. Cash Available for Distribution (CAD) is a non-GAAP financial measure that is not intended to represent cash flow for the period and is not indicative of cash flow provided by operating activities as determined under GAAP. CAD is calculated in accordance with the current Nareit definition as FFO minus normalized recurring real estate-related expenditures and other non-cash items, nonrecurring expenditures and the unconsolidated real estate venture’s allocated share of these adjustments. CAD is presented solely as a supplemental disclosure because the Company believes it provides useful information regarding the Company’s ability to fund its dividends. Because all companies do not calculate CAD the same way, the presentation of CAD may not be comparable to similarly titled measures of other companies. Core Funds from Operations (Core FFO) adjusts FFO to present an alternative measure of the Company's operating performance, which, when applicable, excludes items which it believes are not representative of ongoing operating results, such as liability management related costs (including losses on extinguishment of debt and modification costs), catastrophic event charges, depreciation of non-real estate assets, provision for (recovery of) credit losses, and the unconsolidated real estate venture's allocated share of these adjustments. In future periods, the Company may also exclude other items from Core FFO that it believes may help investors compare its results. The Company believes Core FFO more accurately reflects the ongoing operational and financial performance of the Company's core business. EBITDA is calculated as the sum of net income (loss) before interest expense, taxes, depreciation and amortization, (gain) loss on the sale of operating properties, impairment loss, and the unconsolidated real estate venture’s allocated share of these adjustments. EBITDA is not intended to represent cash flow for the period, is not presented as an alternative to operating income as an indicator of operating performance, should not be considered in isolation or as a substitute for measures of performance prepared in accordance with GAAP, is not indicative of operating income or cash provided by operating activities as determined under GAAP and may be presented on a pro forma basis. EBITDA is presented solely as a supplemental disclosure with respect to liquidity because the Company believes it provides useful information regarding the Company's ability to service or incur debt. Because all companies do not calculate EBITDA the same way, the presentation of EBITDA may not be comparable to similarly titled measures of other companies. Funds From Operations (FFO) is defined, in accordance with the Nareit FFO White Paper - 2018 Restatement, as net income (loss), calculated in accordance with GAAP, excluding depreciation and amortization related to real estate, gains and losses from the sale of certain real estate assets, gains and losses from change in control and impairment write-downs of certain real estate assets and investments in entities when the impairment is directly attributable to decreases in the value of depreciable real estate held by the entity. FFO includes the Company’s share of FFO generated by unconsolidated affiliates. FFO is a widely recognized measure of REIT performance. Although FFO is a non-GAAP financial measure, the Company believes that information regarding FFO is helpful to shareholders and potential investors. Net Debt and Adjusted Net Debt Net Debt represents the Company's consolidated debt and its share of unconsolidated debt adjusted to exclude its share of unamortized premiums and discounts and deferred financing fees, less its share of cash and cash equivalents and property acquisition closing escrow, net of deposit. By excluding these items, the result provides an estimate of the contractual amount of borrowed capital to be repaid, net of cash available to repay it. The Company believes this calculation constitutes a beneficial supplemental non-GAAP financial disclosure to investors in understanding its financial condition. Adjusted Net Debt is Net Debt reduced by 1) for each project under construction or in design, the lesser of i) outstanding lump-sum reimbursement amounts and ii) the cost to date, 2) 40% times the amount by which the cost to date exceeds total lump-sum reimbursement amounts for each project under construction or in design and 3) outstanding lump-sum reimbursement amounts for projects previously completed. These adjustments are made to 1) remove the estimated portion of each project under construction, in design or previously completed that has been financed with debt which may be repaid with outstanding cost reimbursement payments from the US Government and 2) remove the estimated portion of each project under construction or in design, in excess of total lump-sum reimbursements, that has been financed with debt but has not yet produced earnings. See page 28 of the Company’s Q1 2026 Supplemental Information Package for further information. The Company’s method of calculating Net Debt and Adjusted Net Debt may be different from methods used by other REITs and may be presented on a pro forma basis. Accordingly, the Company's method may not be comparable to such other REITs. Other Definitions Fully diluted basis assumes the exchange of all outstanding common units representing limited partnership interests in the Company’s operating partnership, or common units, the full vesting of all shares of restricted stock, and the exchange of all earned and vested LTIP units in the Company’s operating partnership for shares of common stock on a one-for-one basis, which is not the same as the meaning of “fully diluted” under GAAP. Conference Call Information The Company will host a webcast and conference call at 11:00 am Eastern time on April 27, 2026 to review the first quarter 2026 performance, discuss recent events and conduct a question-and-answer session. A live webcast will be available in the Investor Relations section of the Company’s website. Shortly after the webcast, a replay of the webcast will be available on the Investor Relations section of the Company's website for up to twelve months. Please note that the full text of the press release and supplemental information package are also available through the Company’s website at ir.easterlyreit.com. About Easterly Government Properties, Inc. Easterly Government Properties, Inc. (NYSE: DEA) is based in Washington, D.C., and focuses primarily on the acquisition, development and management of Class A commercial properties that are leased to the U.S. Government. Easterly’s experienced management team brings specialized insight into the strategy and needs of mission-critical U.S. Government agencies for properties leased to such agencies either directly or through the U.S. General Services Administration (GSA). For further information on the company and its properties, please visit www.easterlyreit.com. Forward Looking Statements We make statements in this press release that are considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions and include our guidance with respect to Net income (loss) and Core FFO per share on a fully diluted basis. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and are including this statement in this press release for purposes of complying with those safe harbor provisions. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors that are beyond our control including, without limitation: risks associated with our dependence on the U.S. Government and its agencies for substantially all of our revenues, including credit risk and risk that the U.S. Government reduces its spending on real estate or that it changes its preference away from leased properties, including as a result of or in connection with any shutdown of the U.S. Government; risks associated with ownership and development of real estate; the risk of decreased rental rates or increased vacancy rates; the loss of key personnel; general volatility of the capital and credit markets and the market price of our common stock; the risk we may lose one or more major tenants; difficulties in completing and successfully integrating acquisitions; failure of acquisitions or development projects to occur at anticipated levels or yield anticipated results; risks associated with our joint venture activities; risks associated with actual or threatened terrorist attacks; intense competition in the real estate market that may limit our ability to attract or retain tenants or re-lease space; insufficient amounts of insurance or exposure to events that are either uninsured or underinsured; uncertainties and risks related to adverse weather conditions, natural disasters and climate change; exposure to liability relating to environmental and health and safety matters; limited ability to dispose of assets because of the relative illiquidity of real estate investments and the nature of our assets; exposure to litigation or other claims; risks associated with breaches of our data security; risks associated with our indebtedness, including failure to refinance current or future indebtedness on favorable terms, or at all, failure to meet the restrictive covenants and requirements in our existing and new debt agreements, fluctuations in interest rates and increased costs to refinance or issue new debt; risks associated with derivatives or hedging activity; risks associated with mortgage debt or unsecured financing or the unavailability thereof, which could make it difficult to finance or refinance properties and could subject us to foreclosure; adverse impacts from any future pandemic, epidemic or outbreak of any highly infectious disease on the U.S., regional and global economies and our financial condition and results of operations; and other risks and uncertainties detailed in the “Risk Factors” section of our Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission (SEC) on February 23, 2026, and under the heading “Risk Factors” in our other public filings. In addition, our anticipated qualification as a real estate investment trust involves the application of highly technical and complex provisions of the Internal Revenue Code of 1986, or the Code, and depends on our ability to meet the various requirements imposed by the Code through actual operating results, distribution levels and diversity of stock ownership. We assume no obligation to update publicly any forward looking statements, whether as a result of new information, future events or otherwise. Balance Sheet (Unaudited, in thousands, except share amounts) March 31, 2026 December 31, 2025 Assets Real estate properties, net $ 2,738,755 $ 2,714,650 Cash and cash equivalents 2,017 23,374 Restricted cash 10,661 10,257 Tenant accounts receivable 73,041 51,493 Investment in unconsolidated real estate venture 304,070 304,721 Real estate loans receivable, net and investment in sales-type lease, net 44,462 34,286 Intangible assets, net 189,534 183,911 Prepaid expenses and other assets 57,520 57,078 Total assets $ 3,420,060 $ 3,379,770 Liabilities Revolving credit facility 245,050 199,050 Term loan facilities, net 297,479 297,200 Notes payable, net 1,019,132 1,018,884 Mortgage notes payable, net 150,054 151,191 Intangible liabilities, net 13,598 11,959 Deferred revenue 230,031 219,201 Interest rate swaps 1,010 3,034 Accounts payable, accrued expenses and other liabilities 108,203 109,686 Total liabilities 2,064,557 2,010,205 Equity Common stock, par value $0.01, 80,000,000 shares authorized, 46,444,374 and 46,303,469 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively 464 463 Additional paid-in capital 1,961,587 1,958,412 Retained earnings 146,222 144,857 Cumulative dividends (796,880 ) (776,022 ) Accumulated other comprehensive loss (2,554 ) (4,578 ) Total stockholders' equity 1,308,839 1,323,132 Non-controlling interest in Operating Partnership 46,664 46,433 Total equity 1,355,503 1,369,565 Total liabilities and equity $ 3,420,060 $ 3,379,770 Income Statement (Unaudited, in thousands, except share and per share amounts) Three Months Ended March 31, 2026 March 31, 2025 Revenues Rental income $ 88,593 $ 75,546 Tenant reimbursements 804 1,026 Asset management income 646 622 Other income 1,502 1,481 Total revenues 91,545 78,675 Expenses Property operating 20,536 17,799 Real estate taxes 8,532 7,957 Depreciation and amortization 33,221 26,797 Acquisition costs 649 307 Corporate general and administrative 8,495 6,215 Provision for (recovery of) credit losses 196 (238 ) Total expenses 71,629 58,837 Other income (expense) Income from unconsolidated real estate venture 1,664 1,822 Interest expense, net (20,166 ) (18,377 ) Net income 1,414 3,283 Non-controlling interest in Operating Partnership (49 ) (156 ) Net income available to Easterly Government Properties, Inc. $ 1,365 $ 3,127 Net income available to Easterly Government Properties, Inc. per share: Basic $ 0.02 $ 0.07 Diluted $ 0.02 $ 0.07 Weighted-average common shares outstanding: Basic 46,260,517 43,224,145 Diluted 46,453,599 43,372,207 Net income, per share - fully diluted basis $ 0.03 $ 0.07 Weighted average common shares outstanding - fully diluted basis 47,996,434 45,420,667 EBITDA (Unaudited, in thousands) Three Months Ended March 31, 2026 March 31, 2025 Net income $ 1,414 $ 3,283 Depreciation and amortization 33,221 26,797 Interest expense 20,166 18,377 Tax expense 111 163 Unconsolidated real estate venture allocated share of above adjustments 2,340 2,341 EBITDA $ 57,252 $ 50,961 Pro forma adjustments(1) 188 Pro forma EBITDA $ 57,440 (1) Pro forma assuming a full quarter of operations from the three operating properties acquired in the first quarter of 2026. FFO and CAD (Unaudited, in thousands, except share and per share amounts) Three Months Ended March 31, 2026 March 31, 2025 Net income $ 1,414 $ 3,283 Depreciation of real estate assets 32,955 26,546 Unconsolidated real estate venture allocated share of above adjustments 2,281 2,279 FFO $ 36,650 $ 32,108 Adjustments to FFO: Loss on extinguishment of debt and modification costs $ - $ 900 Provision for (recovery of) credit losses 196 (238 ) Natural disaster event expense, net of recovery 15 23 Depreciation of non-real estate assets 267 251 Unconsolidated real estate venture allocated share of above adjustments 17 17 Core FFO $ 37,145 $ 33,061 FFO, per share - fully diluted basis $ 0.76 $ 0.71 Core FFO, per share - fully diluted basis $ 0.77 $ 0.73 Core FFO $ 37,145 $ 33,061 Straight-line rent and other non-cash adjustments (2,007 ) 251 Amortization of above-/below-market leases (435 ) (518 ) Amortization of deferred revenue (3,704 ) (1,762 ) Non-cash interest expense 939 759 Non-cash compensation 2,097 1,421 Natural disaster event expense, net of recovery (15 ) (23 ) Principal amortization (1,190 ) (1,127 ) Maintenance capital expenditures (657 ) (285 ) Contractual tenant improvements (49 ) (612 ) Unconsolidated real estate venture allocated share of above adjustments 29 (20 ) Cash Available for Distribution (CAD) $ 32,153 $ 31,145 Weighted average common shares outstanding - fully diluted basis 47,996,434 45,420,667 Net Debt and Adjusted Net Debt (Unaudited, in thousands) March 31, 2026 Total Debt(1) $ 1,720,560 Less: Cash and cash equivalents (3,964 ) Net Debt $ 1,716,596 Less: Adjustment for development projects(2) (49,099 ) Adjusted Net Debt $ 1,667,497 1 Excludes unamortized premiums / discounts and deferred financing fees. 2 See definition of Adjusted Net Debt on Page 4 of this release. More News From Easterly Government Properties, Inc. |
|||
|
Saved
2026-06-12 21:14
1mo ago
Published
2026-04-27 15:31
3mo ago
|
Easterly Government Properties, Inc. (DEA) Q1 2026 Earnings Call Transcript | FMP Stock News | |
|
Original source text
Easterly Government Properties, Inc. (DEA) Q1 2026 Earnings Call Transcript |
|||
|
Saved
2026-06-12 21:14
1mo ago
Published
2026-04-29 15:43
3mo ago
|
Trulieve Announces Applications Filed for DEA Registration of State Licensed Medical Marijuana Businesses | FMP Stock News | |
|
Original source text
, /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced that it has filed applications with the U.S. Drug Enforcement Administration (DEA) to register certain state‑licensed medical marijuana operations pursuant to the expedited registration pathway established by the recent rescheduling of medical marijuana to Schedule III under the Controlled Substances Act."DEA registration for our medical business marks a historic step forward for Trulieve and the patients we serve," said Trulieve Chief Executive Officer Kim Rivers. "With over 200 dispensaries serving only medical patients, Trulieve is uniquely positioned to set the bar as a responsible operator in U.S. cannabis." Following the reclassification of medical marijuana to Schedule III, the DEA established an expedited registration process for eligible state‑licensed medical marijuana operators. For operators that apply within 60 days, licensure to manufacture, distribute, and dispense Schedule III medical marijuana products is deemed approved unless otherwise notified. About Trulieve Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with established hubs in the Northeast, Southeast, and Southwest, anchored by cornerstone markets in Arizona, Florida, Ohio, and Pennsylvania. Driven by a core mission to expand access to cannabis, Trulieve serves customers with innovative, high-quality branded products and exceptional experiences. With scaled operations in attractive markets and targeted expansion through its hub strategy, Trulieve is poised for accelerated growth. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com. Facebook: @Trulieve Instagram: @Trulieve X: @Trulieve Investor and Media Contact Christine Hersey, Chief Corporate Affairs and Strategy Officer +1 (424) 202-0210 [email protected] SOURCE Trulieve Cannabis Corp. |
|||
|
Saved
2026-06-12 21:14
1mo ago
Published
2026-05-01 08:41
2mo ago
|
Easterly Government Properties: Rate Pressure Grows, But Major Opportunity Remains | FMP Stock News | |
|
Original source text
Easterly Government Properties remains a buy, supported by resilient government-backed leases and a significant margin of safety implied in the current valuation. DEA's Q1 results were solid, with FFO in line and revenue slightly beating expectations; core FFO guidance was raised at the low end, reflecting new mezzanine lending activity. The company's $1.5 billion long-term pipeline and sustainable ~7.77% yield are offset by high borrowing costs and macro risks, particularly from inflation and delayed Fed rate cuts. |
|||
|
Saved
2026-06-12 21:14
1mo ago
Published
2026-05-04 08:00
2mo ago
|
Easterly Government Properties to Participate in Wells Fargo 29th Annual Real Estate Securities Conference | FMP Stock News | |
|
Original source text
-WASHINGTON--(BUSINESS WIRE)--Easterly Government Properties, Inc. (NYSE: DEA), a fully integrated real estate investment trust focused primarily on the acquisition, development and management of Class A commercial properties leased to the U.S. Government and its adjacent partners, announced today that management will participate in investor meetings at Wells Fargo’s 29th Annual Real Estate Securities Conference in Charleston, South Carolina on May 4, 2026. Electronic copies of the written materials to be provided to investors in connection with the meetings can be found in the Presentation section of the Company’s Investor Relations website at ir.easterlyreit.com. About Easterly Government Properties, Inc. Easterly Government Properties, Inc. (NYSE: DEA) is based in Washington, D.C., and focuses primarily on the acquisition, development and management of Class A commercial properties that are leased to the U.S. Government and its adjacent partners. Easterly’s experienced management team brings specialized insight into the strategy and needs of mission-critical U.S. Government agencies for properties leased to such agencies either directly or through the U.S. General Services Administration (GSA). For further information on the company and its properties, please visit www.easterlyreit.com. More News From Easterly Government Properties, Inc. Back to Newsroom |
|||
|
Saved
2026-06-12 21:14
1mo ago
Published
2026-05-06 07:30
2mo ago
|
Glass House Brands Announces Application for DEA Registration of Certain Medical Operations | FMP Stock News | |
|
Original source text
May 06, 2026 07:30 ET | Source: Glass House Brands Inc.LONG BEACH, Calif. and TORONTO, May 06, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF) today announced that it has submitted applications to register certain California-licensed medical cannabis operations with the U.S. Drug Enforcement Administration (DEA) pursuant to the expedited registration pathway established by the recent rescheduling of medical cannabis to Schedule III under the Controlled Substances Act. In connection with the Schedule III reclassification of medical cannabis, the DEA established an expedited registration process for eligible state-licensed medical marijuana operators. Medical cannabis dispensaries that register with the DEA during the 60-day window may operate under Schedule III while the DEA processes those applications. The Company will discuss the rescheduling of medical cannabis as well as recent financial results on its first quarter investor call scheduled for Wednesday, May 13, 2026 at 5:00 p.m. Eastern Time. About Glass House Brands Glass House is one of the fastest-growing, vertically integrated cannabis companies in the U.S., with a dedicated focus on the California market and building leading, lasting brands to serve consumers across all segments. Whether it be through its portfolio of brands, which includes Glass House Farms, PLUS Products, Allswell and Mama Sue Wellness or its network of retail dispensaries throughout the state of California, which includes The Farmacy, Natural Healing Center and The Pottery, Glass House is committed to realizing its vision of excellence: outstanding cannabis products, produced sustainably, for the benefit of all. For more information and company updates, visit www.glasshousebrands.com/ and https://ir.glasshousebrands.com/contact/email-alerts/. Forward Looking Statements This news release contains certain forward-looking information and forward-looking statements, as defined in applicable securities laws (collectively referred to herein as “forward-looking statements”). Forward-looking statements reflect current expectations or beliefs regarding future events or Glass House’s future performance or financial results. All statements other than statements of historical fact are forward-looking statements. Often, but not always, forward- looking statements can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “continues”, “forecasts”, “projects”, “predicts”, “intends”, “anticipates”, “targets” or “believes”, or variations of, or the negatives of, such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “should”, “might” or “will” be taken, occur or be achieved. All forward-looking statements, including those herein, are qualified by this cautionary statement. Although Glass House believes that the expectations expressed in such statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the statements. Accordingly, readers should not place undue reliance on forward-looking statements. There are certain factors that could cause actual results to differ materially from those in the forward-looking information, including those risks disclosed in the Glass House’s Annual Information Form available on SEDAR+ at www.sedarplus.ca and in Glass House’s Form 40-F available on EDGAR at www.sec.gov. For more information on Glass House, investors are encouraged to review Glass House’s public filings on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. The forward-looking statements and financial outlooks contained in this news release speak only as of the date of this news release or as of the date or dates specified in such statements. Glass House disclaims any intention or obligation to update or revise any forward- looking information, whether as a result of new information, future events or otherwise, other than as required by law. For further information, please contact: Glass House Brands Inc. Jon DeCourcey, Vice President of Investor Relations T: (781) 724 6869 E: [email protected] Investor Relations Contact: KCSA Strategic Communications Phil Carlson T: 212-896-1233 E: [email protected] |
|||
|
Saved
2026-06-12 21:14
1mo ago
Published
2026-05-08 08:30
2mo ago
|
LEEF Brands Files Applications for DEA Registration, Positioning for Interstate and Global Export Opportunities | FMP Stock News | |
|
Original source text
VANCOUVER, British Columbia, May 08, 2026 (GLOBE NEWSWIRE) -- LEEF Brands, Inc. (CSE: LEEF) (OTCQB: LEEEF) (“LEEF” or the “Company”), a rapidly growing cannabis company, today announced that it has filed applications for registration with the U.S. Drug Enforcement Administration (“DEA”) following recent federal cannabis rescheduling developments.The applications are a key step in positioning LEEF to participate in potential interstate commerce and international export channels as regulatory frameworks evolve. To support this process, LEEF has engaged attorney Shane Pennington, Partner at Blank Rome, and a leading expert in DEA licensing and regulatory strategy. “Rescheduling is the most significant change our industry has seen in over 50 years,” said Micah Anderson, Chief Executive Officer of LEEF Brands. “We’ve spent years building a low-cost, vertically integrated platform designed for this moment. For the first time in this industry’s history, federal policy is moving in a direction that makes what we do more valuable, not less.” LEEF is currently profitable operating in California — one of the most competitive and lowest-priced cannabis markets in the world — driven by its vertically integrated model and in-house cultivation at Salisbury Canyon Ranch. Interstate and global exports are expected to provide an opportunity to sell into other markets at meaningfully higher prices. LEEF’s platform includes one of the world’s largest cannabis farms and one of the highest-capacity, most sophisticated extraction labs. The Company believes this platform positions it to supply both the U.S. and global markets. While regulatory timelines remain uncertain, LEEF is actively preparing to participate as opportunities emerge. About LEEF Brands, Inc. LEEF Brands, Inc. is a leading California and New York-based extraction and manufacturing cannabis company. With a comprehensive supply chain, innovative manufacturing processes, a dynamic bulk concentrate portfolio, and a growing line of branded products, LEEF powers some of the largest cannabis brands in the United States. For more information, visit www.leefbrands.com. Forward-Looking Statements This news release contains certain forward-looking information and forward-looking statements, as defined in applicable securities laws (collectively, “forward-looking statements”), including, but not limited to, statements regarding the Company’s future financial condition, operations, and objectives. Forward-looking statements reflect current expectations or beliefs regarding future events or the Company’s future performance or financial results. All statements other than statements of historical fact are forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “continues”, “forecasts”, “projects”, “predicts”, “intends”, “anticipates”, “targets” or “believes”, or variations of, or the negatives of, such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “should”, “might” or “will” be taken, occur or be achieved. All forward-looking statements, including those herein, are qualified by this cautionary statement. Although the Company believes that the expectations expressed in such statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the statements. There are certain factors that could cause actual results to differ materially from those in the forward-looking information, including, but not limited to, the risks disclosed in the Company’s public filings on the Company’s issuer profile on SEDAR+ at www.sedarplus.ca. Accordingly, readers should not place undue reliance on forward-looking statements. LEEF Brands, Inc. Per: Jesse Redmond Chief Strategy & Investor Relations Officer Phone: +1 (805) 717-9327 Email: [email protected] |
|||
|
Saved
2026-06-12 21:14
1mo ago
Published
2026-05-11 08:00
2mo ago
|
Easterly Government Properties to Participate in BMO Real Assets Conference | FMP Stock News | |
|
Original source text
-WASHINGTON--(BUSINESS WIRE)--Easterly Government Properties, Inc. (NYSE: DEA), a fully integrated real estate investment trust focused primarily on the acquisition, development and management of Class A commercial properties leased to the U.S. Government and its adjacent partners, announced today that management will participate in investor meetings at the BMO Real Assets Conference in New York, NY beginning on May 11th, 2026. Electronic copies of the written materials to be provided to investors in connection with the meetings can be found in the Presentation section of the Company’s Investor Relations website at ir.easterlyreit.com. About Easterly Government Properties, Inc. Easterly Government Properties, Inc. (NYSE: DEA) is based in Washington, D.C., and focuses primarily on the acquisition, development and management of Class A commercial properties that are leased to the U.S. Government and its adjacent partners. Easterly’s experienced management team brings specialized insight into the strategy and needs of mission-critical U.S. Government agencies for properties leased to such agencies either directly or through the U.S. General Services Administration (GSA). For further information on the company and its properties, please visit www.easterlyreit.com. More News From Easterly Government Properties, Inc. Back to Newsroom |
|||
|
Saved
2026-06-12 21:14
1mo ago
Published
2026-05-13 07:00
2mo ago
|
Compass Pathways Announces First Quarter 2026 Financial Results and Business Highlights | FMP Stock News | |
|
Original source text
Compass Pathways Announces First Quarter 2026 Financial Results and Business Highlights Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported first quarter 2026 financial results and business highlights.“With regulatory acceleration unfolding, we are working diligently towards our goal of completing the filing of a robust clinical package by Q4 and securing COMP360 approval,” said Kabir Nath, Chief Executive Officer of Compass Pathways. “COMP360 represents a fundamentally different approach for patients with treatment resistant depression, unlike any other treatment approved today. Its transformative clinical profile has the potential to change what patients can expect in terms of both rapid and durable relief, and we are ready to deliver for those who have waited far too long for better options.” Business Highlights Accelerated regulatory path Approval timelines are tracking to Compass’ fastest projected expectations, supported by regulatory acceleration including a rolling New Drug Application (NDA) submission and the Commissioner’s National Priority Review Voucher (CNPV). NDA rolling submission underway: FDA granted Compass NDA rolling submission and review request, based on strength of positive Phase 3 data. Rolling submission and review are underway, with sections of the NDA already submitted. 26-week (Part B) data from COMP006, expected in early Q3 2026. The final NDA submission remains on track for Q4, aligned with the Company’s previously defined accelerated timing. Post-NDA filing momentum: CNPV awarded for COMP360, Compass’ proprietary formulation of synthetic psilocybin for TRD, which has the potential to accelerate filing review time to be completed within 1-2 months. White House Executive Order on psychedelics treatments directs the Drug Enforcement Administration (DEA) to initiate and complete review of psychedelic treatment that has successfully completed Phase 3 trials so that rescheduling may proceed as quickly as possible. Advancing toward commercial launch Launch readiness: Compass will be launch ready by the end of the year and has assembled a highly experienced commercial leadership team. The team is advancing comprehensive launch preparedness efforts, including KOL and HCP education, payer engagement, and ongoing initiatives to support a timely federal and state rescheduling process. Delivery infrastructure readiness: COMP360 is expected to fit seamlessly across diverse healthcare settings within the current infrastructure of over 7,300 centers1 offering multi-hour treatments Treatment centers are growing rapidly, and existing centers are already scaling in anticipation of a COMP360 launch and additional multi-hour psychedelic treatments coming to market. COMP360’s transformative clinical profile COMP360 has the potential to offer a highly differentiated, transformative clinical profile and is expected to be a blockbuster opportunity. COMP360 is the first classic psychedelic2 to consistently achieve a highly statistically significant result and clinically meaningful effect in 3 large late-stage trials involving more than 1,000 participants living with TRD, with a generally well-tolerated and safe profile. COMP360 demonstrates effects as quickly as within one day after administration with durability lasting at least through 6 months for those who achieve a clinically meaningful response after one or two doses. Financial Highlights Research and development expenses were $26.5 million for the three months ended March 31, 2026, compared with $30.9 million during the same period in 2025. The decrease was primarily driven by lower development expenses, reflecting reduced clinical trial costs as our Phase 3 program for COMP360 psilocybin therapy in TRD progresses toward completion, as well reduced discovery program expenses following the termination of certain programs in connection with the reorganization that took place in the fourth quarter of 2024 and the related contract terminations in 2025. General and administrative expenses were $16.4 million for the three months ended March 31, 2026, compared with $18.7 million during the same period in 2025. The decrease was primarily due to lower legal and professional fees, driven by higher financing-related costs in 2025, including those associated with warrant issuances, which were expensed as incurred, whereas a greater portion of such costs in 2026 were capitalized. This decrease was partially offset by increased consulting and legal advisory expenses. Net income for the three months ended March 31, 2026, was $91.2 million, or $0.71 net income per share (basic) and $0.30 net loss per share (diluted), compared with a net loss of $17.9 million, or $0.20 net loss per share (basic) and $0.24 net loss per share (diluted), during the same period in 2025. The increase in net income was primarily driven by a $130.9 million non-cash gain on fair value adjustment related to our warrants, compared with $19.5 million during the same period in 2025. As the fair value of the warrants fluctuates with our share price, this adjustment can result in significant variability in our reported net income or net loss. Cash and cash equivalents were $466.0 million as of March 31, 2026, compared with $149.6 million as of December 31, 2025. Debt was $50.5 million as of March 31, 2026, compared with $31.6 million as of December 31, 2025. Financial Guidance The current cash position is expected to be sufficient to fund operating expenses and capital expenditure requirements into 2028. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational COMP360 synthetic psilocybin treatment, potentially a first in class treatment. COMP360 has Breakthrough Therapy designation from the US Food and Drug Administration (FDA) and has received Innovative Licensing and Access Pathway (ILAP) designation in the UK for treatment-resistant depression (TRD). Compass is headquartered in London, UK, with offices in New York in the US. We envision a world where mental health means not just the absence of illness but the ability to thrive. Forward-looking statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. In some cases, forward-looking statements can be identified by terminology such as “may”, “might”, “will”, “could”, “would”, “should”, “expect”, “intend”, “plan”, “objective”, “anticipate”, “believe”, “contemplate”, “estimate”, “predict”, “potential”, “continue” and “ongoing,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements include express or implied statements relating to, among other things, statements regarding our expectations regarding our financial guidance; our business strategy and goals; our expectations and projections about the company’s future cash needs and financial results; our expectations regarding the safety or efficacy of our investigational COMP360 psilocybin treatment, including as a treatment of TRD or PTSD; our plans and expectations regarding our clinical trials, including our phase 3 trials in TRD and our phase 2b/3 trial in PTSD; our expectations regarding the time periods for the release of data from Part B of the COMP006 Phase 3 trial for TRD; any implication that past results will be predictive of future results; our expectations regarding the timing of our rolling submission of a new drug application, or NDA, for COMP360 psilocybin treatment in TRD and the timing of the review by the Food and Drug Administration, or FDA, of such NDA, including potential acceleration due to the grant of rolling review and award of a Commissioner’s National Priority Voucher, or CNPV, for COMP360 psilocybin treatment in TRD; the potential for the pivotal phase 3 program in TRD to support regulatory filings and approvals on an accelerated basis or at all; our expectations regarding potential commercial launch timelines and our commercial readiness; our efforts and our ability to obtain regulatory approval and adequate coverage and reimbursement; our ability to transition from a clinical-stage to a commercial-stage organization and effectively launch a commercial product, if regulatory approval is obtained, on an accelerated timeline or at all; and our expectations regarding the benefits of our investigational COMP360 psilocybin treatment, including as a treatment of TRD or PTSD. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Compass’s control and which could cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others: uncertainties associated with risks related to clinical development which is a lengthy and expensive process with uncertain outcomes, and therefore our clinical trials may be delayed or terminated and may be more costly than expected; the full results and safety data from our Phase 3 clinical trials in TRD may not be consistent with the preliminary results to date; our need for additional funding to achieve our business goals and if we are unable to obtain this funding when needed and on acceptable terms, we could be forced to delay, limit or terminate our clinical trials; that the rolling review process and/or the Commissioner's National Priority Voucher pilot program may not actually lead to a faster FDA review or approval process; our efforts to obtain FDA approval, or approval from regulatory authorities in other jurisdictions, for our investigational COMP360 psilocybin treatment on an accelerated basis, or at all, may be unsuccessful; our efforts to commercialize and obtain coverage and reimbursement for our investigational COMP360 psilocybin treatment, if approved, may be unsuccessful; the risk that our strategic collaborations will not continue or will not be successful; and our ability to retain key personnel; and those risks and uncertainties described under the heading “Risk Factors” in Compass’s most recent annual report on Form 10-K or quarterly report on Form 10-Q, the prospectus supplement related to the proposed public offering we plan to file and in other reports we have filed with the U.S. Securities and Exchange Commission (“SEC”), which are available on the SEC’s website at www.sec.gov. Except as required by law, Compass disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Compass’s current expectations and speak only as of the date hereof. References Data on file For the definition of classic psychedelic, see Vollenweider, F.X. and Smallridge, J.W., 2022. Classic psychedelic drugs: update on biological mechanisms. Pharmacopsychiatry, 55(03), pp.121-138 Enquiries Media: Dana Sultan-Rothman, [email protected] Investors: Stephen Schultz, [email protected], +1 401 290 7324 COMPASS PATHWAYS PLC Condensed Consolidated Balance Sheets (unaudited) (in thousands, except share and per share amounts) (expressed in U.S. Dollars, unless otherwise stated) March 31, December 31, 2026 2025 ASSETS CURRENT ASSETS: Cash and cash equivalents $466,010 $149,608 Restricted cash 379 379 Prepaid expenses and other current assets 44,478 41,503 Total current assets 510,867 191,490 NON-CURRENT ASSETS: Operating lease right-of-use assets 2,861 3,424 Deferred tax assets 4,098 3,751 Long-term prepaid expenses and other assets 13,913 11,684 Total assets $531,739 $210,349 LIABILITIES AND SHAREHOLDERS' EQUITY/(DEFICIT) CURRENT LIABILITIES: Accounts payable $10,877 $15,222 Accrued expenses and other liabilities 8,984 9,214 Debt, current portion — 17,523 Operating lease liabilities - current 2,054 2,110 Warrant liabilities 131,882 203,726 Total current liabilities 153,797 247,795 NON-CURRENT LIABILITIES: Debt, non-current portion 50,476 14,110 Operating lease liabilities - non-current 779 1,292 Total liabilities $205,052 $263,197 SHAREHOLDERS' EQUITY/(DEFICIT): Ordinary shares, £0.008 par value; 134,923,295 and 96,085,785 shares authorized, issued and outstanding at March 31, 2026 and December 31, 2025, respectively 1,393 973 Additional paid-in capital 1,071,481 783,562 Accumulated other comprehensive loss (14,795) (14,789) Accumulated deficit (731,392) (822,594) Total shareholders' equity/(deficit) 326,687 (52,848) Total liabilities and shareholders' equity/(deficit) $531,739 $210,349 COMPASS PATHWAYS PLC Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) (in thousands, except share and per share amounts) (expressed in U.S. Dollars, unless otherwise stated) Three Months ended March 31, 2026 2025 OPERATING EXPENSES: Research and development $26,480 $30,880 General and administrative 16,424 18,736 Total operating expenses 42,904 49,616 Loss from operations: (42,904) (49,616) OTHER INCOME (EXPENSE), NET: Fair value change of warrant liabilities 130,916 19,460 Benefit from R&D tax credit 2,477 8,448 Interest income 2,419 2,386 Interest expense (1,465) (1,124) Foreign exchange (losses) gains (736) 2,133 Other income 484 803 Total other income, net 134,095 32,106 Income (loss) before income taxes 91,191 (17,510) Income tax benefit (expense) 11 (354) Net income (loss) $91,202 $(17,864) Net income (loss) per share attributable to ordinary shareholders: basic $0.71 $(0.20) Weighted average ordinary shares outstanding: basic 110,064,581 89,192,252 Net loss per share attributable to ordinary shareholders: diluted $(0.30) $(0.24) Weighted average ordinary shares outstanding: diluted 130,266,693 98,641,623 Net income (loss) $91,202 $(17,864) Other comprehensive income (loss): Foreign exchange translation adjustment (6) (117) Comprehensive income (loss) $91,196 $(17,981) View source version on businesswire.com: https://www.businesswire.com/news/home/20260513826535/en/ |
|||
|
Saved
2026-06-12 21:13
1mo ago
Published
2026-05-26 11:06
2mo ago
|
Bank On Higher Interest Rates With Bigger Income | FMP Stock News | |
|
Original source text
Federal bond yields act as financial gravity—when they surge, stable, cash-flowing real estate automatically goes on sale. DEA's Government Shield: Easterly secures 86% of its rental revenue directly from the U.S. government, creating a recession-resistant dividend. Federal budget constraints are forcing the government to lease more space rather than own it, directly benefiting the DEA. |
|||
|
Saved
2026-06-12 21:13
1mo ago
Published
2026-05-27 16:30
2mo ago
|
Easterly Government Properties to Participate at Nareit's REITweek 2026 Investor Conference | FMP Stock News | |
|
Original source text
-WASHINGTON--(BUSINESS WIRE)--Easterly Government Properties, Inc. (NYSE: DEA) (the “Company” or “Easterly”), a fully integrated real estate investment trust focused primarily on the acquisition, development and management of Class A commercial properties leased to the U.S. Government and its adjacent partners, announced today that management will present at Nareit’s REITweek 2026 Investor Conference (the “Conference”) in New York, New York on June 2, 2026 from 9:30 – 10:00 AM Eastern Time. The Company will also participate in investor meetings from June 2 – 3, 2026. For investors interested in listening to the presentation, the live audio-webcast will be provided in listen-only mode in the Presentation section of the Company’s Investor Relations website at ir.easterlyreit.com, and at the following link: Easterly Government Properties Webcast. A replay of the webcast will be available for 60 days following the presentation. Electronic copies of any materials to be provided to investors at the Conference will also be made available in the Presentation section of the Company’s Investor Relations website prior to the start of the Conference. About Easterly Government Properties, Inc. Easterly Government Properties, Inc. (NYSE: DEA) is based in Washington, D.C., and focuses primarily on the acquisition, development and management of Class A commercial properties that are leased to the U.S. Government and its adjacent partners. Easterly’s experienced management team brings specialized insight into the strategy and needs of mission-critical U.S. Government agencies for properties leased to such agencies either directly or through the U.S. General Services Administration (GSA). For further information on the company and its properties, please visit www.easterlyreit.com. More News From Easterly Government Properties, Inc. Back to Newsroom |
|||
|
Saved
2026-06-12 21:13
1mo ago
Published
2026-06-02 01:15
1mo ago
|
The Market Overreacted to the DEA's Marijuana Rescheduling -- Here's What It Means for Canopy Growth Stock Now | FMP Stock News | |
|
Original source text
A long-awaited change in U.S. federal marijuana law occurred in late April, when the Drug Enforcement Administation rescheduled marijuana from its high-risk Schedule I to a Schedule III designation, which is for drugs with accepted medical use and low potential for dependence. The move was initially seen as a historic change for the drug and the industry that's grown up around it.However, the impact thus far has been relatively muted. Nevertheless, the reform will make a difference to certain cannabis companies. Let's look at how it might -- or, more appropriately, might not -- affect one of Canada's top marijuana companies, Canopy Growth (CGC 0.49%). Image source: Getty Images. Medical relief The very large catch in the DEA's rescheduling of cannabis is that it applies solely to medical marijuana, not the recreational variety. And medical is restricted, logically enough, to users deemed to have at least one affliction that the drug can treat. Nevertheless, for some purveyors of pot destined for healthcare use, this is going to make a difference both operationally and financially. The most crucial of these changes, arguably, is that, in the shift from Schedule I to III, medical product sales are no longer subject to Internal Revenue Service Section 280E. That means companies selling them are no longer limited to deducting only their cost of goods sold; they can also deduct standard business expenses (marketing/advertising, rent, salaries, insurance, and so on). While this might not exactly result in a windfall for cannabis companies, it provides plenty of relief for those involved in the medical segment. But again, there's a catch here -- Health Canada, that country's healthcare regulator, narrowly limits cannabis export permits to certain medical or research uses. Therefore, north-of-the-border cannabis companies don't have an easy channel to the U.S. for medical products. Canopy Growth, of course, is a presence on the U.S. market anyway, albeit at some distance. It has an affiliate, Canopy USA, in which it holds only a non-controlling interest, to maintain its clutch of American assets (including medical pot businesses). Of course, there's a catch: The parent company cannot consolidate Canopy USA's results into its own. So ultimately, we don't have a good fix on how much medical weed Canopy's U.S. "affiliate" sells. Also, absent more meaningful legal reform, this situation won't change, and these sales will remain unconsolidated. This company needs more than a legal shift It's likely that this situation is a major reason Canopy Growth officials haven't broken out the party hats. The change will directly affect it when, or if, it graduates to a controlling interest in Canopy USA. Only then can the unit's results be incorporated into its own. So what are we left with here? Canopy Growth is one of Canada's top pot companies, but given the industry's many struggles, that's not an enviable position. Net profits have been very far and few between, and net losses have been considerable at times. The company's free cash flow habitually runs negative as well. Today's Change ( -0.49 %) $ -0.01 Current Price $ 1.00 A clutch of acquisitions hasn't helped lift it into the black; meanwhile, frequent (and often substantial) secondary share issues have left early investors much diluted and, surely, more than a little disappointed. Legalization in the U.S., or at least a fuller rescheduling of marijuana, is the pearl that many a Canadian pot company with an eye on this country clutches to. However, I'm not convinced this will be a magic success maker for any weed business, least of all Canopy Growth; the U.S. market is already competitive, and those Canopy USA units aren't collectively powerful enough to dominate what's still a fragmented industry. The Great Marijuana Rescheduling of 2026, which in the end wasn't so great, isn't going to affect Canopy Growth in any material way. At least, not soon. And given how the company continues to perform, I don't think its stock is a buy. |
|||
|
Saved
2026-06-12 21:13
1mo ago
Published
2026-06-05 07:05
1mo ago
|
My 2 Favorite 7%+ Yielding REIT Investments Today | FMP Stock News | |
|
Original source text
REITs are looking increasingly compelling in the current environment. I detail my favorite 7%+ yielding REIT investment opportunities right now. I share the risks and the upside potential for both of them. |
|||